The effects of transdemal glycerol trinitrate administration on the ischemic limb for vascular intermittent claudication

The effects of transdemal glycerol trinitrate administration on the ischemic limb for vascular intermittent claudication - Transdemal glycerol trinitrate administration on the ischemic limb

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000003707

Enrollment

Registered

2010-06-04

Start date

2009-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

peripheral arterial disease

Interventions

transdermal administration of glycerol trinitrate tape on the ischemic limbs/ on the chest

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients having intermittent claudication due to peripheral arterial disease

Exclusion criteria

Exclusion criteria: 1 Patients who can not do ankle exercise 2 Patients with severe cardiac or respiratory dysfunction 3 Patients that can not be stopped oral intake and medications 4 Patients with hypersensitivity to glycerol trinitrate tape 5 Patients with history of glycerol trinitrate adverse effect 6 Patient with lower limb paralysis 7 Patients are registered in other trials

Design outcomes

Primary

Measure	Time frame
resting and post-exercise calf blood flow, pain-free and maximum exercise times	—

Countries

Japan

Contacts

Public ContactAkira Sato

Graduate School of Medicine Tohoku University Division of Advanced surgical Science and Technology

attkas@med.tohoku.ac.jp022-717-7214

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026